Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1-CYP11A1 interaction.
Liu Y, Jiang JJ, Du SY, Mu LS, Fan JJ, Hu JC, Ye Y, Ding M, Zhou WY, Yu QH, Xia YF, Xu HY, Shi YJ, Qian SW, Tang Y, Li W, Dang YJ, Dong X, Li XY, Xu CJ, Tang QQ.
Science. 2024 Jun 14;384(6701):eadk5382. doi: 10.1126/science.adk5382. Epub 2024 Jun 14.
The latest reports and treatment methods on polycystic ovary syndrome.
Stańczak NA, Grywalska E, Dudzińska E.
Ann Med. 2024 Dec;56(1):2357737. doi: 10.1080/07853890.2024.2357737. Epub 2024 Jul 4.
Polycystic ovary syndrome.
Stener-Victorin E, Teede H, Norman RJ, Legro R, Goodarzi MO, Dokras A, Laven J, Hoeger K, Piltonen TT.
Nat Rev Dis Primers. 2024 Apr 18;10(1):27. doi: 10.1038/s41572-024-00511-3.
Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation.
Su P, Chen C, Sun Y.
J Ovarian Res. 2025 Feb 20;18(1):34. doi: 10.1186/s13048-025-01621-6.
Female pseudohermaphroditism.
IBBERTSON HK, FRASER R.
Proc R Soc Med. 1958 Sep;51(9):723-4.
Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome: a comprehensive update.
Herlin MK, Petersen MB, Brännström M.
Orphanet J Rare Dis. 2020 Aug 20;15(1):214. doi: 10.1186/s13023-020-01491-9.
Polycystic Ovary Syndrome in Adolescents.
Saleh FL, Starkman H, Furness A, Pfeifer SM, Kives S.
Obstet Gynecol Clin North Am. 2024 Dec;51(4):679-693. doi: 10.1016/j.ogc.2024.08.005. Epub 2024 Sep 20.
Mayer-Rokitansky-Kuster-Hauser syndrome.
Novoa CCT, Leite MTC, Sartori MGF.
Rev Bras Ginecol Obstet. 2025 May 16;47:e-FPS4. doi: 10.61622/rbgo/2025FPS4. eCollection 2025.
[Female pseudohermaphroditism].
JUILLARD E.
Rev Med Suisse Romande. 1953 Jul;73(7):660-73.
Androgens drive SLC1A5-dependent metabolic reprogramming in polycystic ovary syndrome.
Wang Y, Wu J, Zhang G, Shi Y, Meng Y, Lv P, Huang W, Su Y, Zhou Z, Wang B, Chen X, Zhou C, Pan J, Jin L, Wang X, Wu Y, Sheng J, Liu X, Zhang Y, Ding G, Yu C, Huang H.
Nat Commun. 2025 Aug 15;16(1):7611. doi: 10.1038/s41467-025-62951-z.
